Jennifer K. Moses

Insider Reports History

Entity
Individual
Location
79 Tw Alexander Drive, 4501 Research Commons, Suite 100, Research Triangle Park, NC
Signature
/s/ Jennifer Tousignant, Attorney-in-Fact for Jennifer K. Moses
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer K. Moses:

Stock Role Class Num Shares Value Price $ Report Date Ownership
G1 Therapeutics, Inc. CFO Common Stock 57.8K $170K $2.94 Jan 5, 2023 Direct
G1 Therapeutics, Inc. CFO Stock Options (Right to buy) 44.6K Jan 3, 2023 Direct
Viridian Therapeutics, Inc.\DE Director Stock Option (Right to Buy) 21K Jun 26, 2024 Direct

Insider Reports Filed by Jennifer K. Moses

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRDN Viridian Therapeutics, Inc.\DE Jun 26, 2024 1 $0 4 Jun 28, 2024 Director
VRDN Viridian Therapeutics, Inc.\DE Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
GTHX G1 Therapeutics, Inc. Jan 3, 2023 4 -$13.1K 4 Jan 5, 2023 CFO
VRDN Viridian Therapeutics, Inc.\DE Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
GTHX G1 Therapeutics, Inc. Feb 1, 2022 4 $9.58K 4 Feb 2, 2022 CFO
GTHX G1 Therapeutics, Inc. Jan 3, 2022 3 -$15.3K 4 Jan 5, 2022 CFO
VRDN Viridian Therapeutics, Inc.\DE Jul 14, 2021 1 $0 4 Jul 15, 2021 Director
VRDN Viridian Therapeutics, Inc.\DE Jul 14, 2021 0 $0 3 Jul 15, 2021 Director